A New Concept in Defibrillation Therapy
Cameron Health has developed the S-ICD® System, the world’s first and only subcutaneous implantable defibrillator that provides protection from sudden cardiac arrest (SCA) while leaving the heart and vasculature untouched. Boston Scientific Corporation acquired this technology through the acquisition of Cameron Health, Inc in June 2012.
Like transvenous ICDs, the S-ICD System utilizes a pulse generator capable of delivering life-saving high-energy shocks to convert VT/VF. Unlike transvenous ICDs, the S-ICD System is implanted in the lateral thoracic region of the body and utilizes a subcutaneous electrode instead of transvenous leads to both sense and deliver therapy. The S-ICD System provides a new solution for a broad range of patient at risk for sudden cardiac arrest.
The S-ICD System has received both CE Mark and FDA approval.